Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PXD101 (Belinostat) in Malignant Pleural Mesothelioma
NCT00365053Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 2006
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of belinostat in malignant pleural mesothelioma (MPM), sponsored by National Cancer Institute. Started Jun 2006; status: completed.
02
Drugs
belinostat
03
Conditions
malignant pleural mesothelioma (MPM)
Beyond the preview
Go deeper on NCT00365053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00365053.